Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) EBITDA: 2018-2025

Historic EBITDA for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to -$15.3 million.

  • Evolus' EBITDA rose 20.68% to -$15.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.0 million, marking a year-over-year decrease of 4.44%. This contributed to the annual value of -$50.9 million for FY2024, which is 17.61% up from last year.
  • As of Q3 2025, Evolus' EBITDA stood at -$15.3 million, which was up 9.63% from -$16.9 million recorded in Q2 2025.
  • Over the past 5 years, Evolus' EBITDA peaked at $6.4 million during Q1 2021, and registered a low of -$23.5 million during Q2 2022.
  • Over the past 3 years, Evolus' median EBITDA value was -$15.3 million (recorded in 2025), while the average stood at -$14.9 million.
  • Per our database at Business Quant, Evolus' EBITDA spiked by 132.80% in 2021 and then slumped by 375.02% in 2022.
  • Quarterly analysis of 5 years shows Evolus' EBITDA stood at -$18.2 million in 2021, then grew by 27.75% to -$13.1 million in 2022, then increased by 11.28% to -$11.7 million in 2023, then skyrocketed by 39.86% to -$7.0 million in 2024, then increased by 20.68% to -$15.3 million in 2025.
  • Its last three reported values are -$15.3 million in Q3 2025, -$16.9 million for Q2 2025, and -$18.8 million during Q1 2025.